bims-mibica Biomed News
on Mitochondrial bioenergetics in cancer
Issue of 2026–11–22
eight papers selected by
Kelsey Fisher-Wellman, Wake Forest University



  1. Methods Cell Biol. 2026 ;pii: S0091-679X(26)00188-3. [Epub ahead of print]211 1-24
      The BCL-2 family comprises pro- and anti-apoptotic proteins that integrate cellular stress signals to regulate mitochondrial apoptosis, with BAX serving as the central executioner that determines commitment to cell death. BAX activation proceeds through a continuum of events including conformational rearrangement of cytosolic BAX, mitochondrial translocation and insertion, and assembly into higher-order oligomers that induce mitochondrial outer membrane permeabilization (MOMP). This chapter presents complementary biochemical methods to monitor each step: (i) resolution of BAX monomer/dimer/oligomer species by blue-native PAGE (BN-PAGE) or size-exclusion chromatography (SEC) of cytosolic and mitochondrial fractions and immunoblotting; (ii) detection of early activation using conformation-specific 6A7 immunoprecipitation; (iii) quantification of mitochondrial translocation by subcellular fractionation and immunoblotting; and (iv) functional assessment of MOMP by immunoblot detection of cytochrome c release and decrease of mitochondrial membrane potential using potentiometric dyes. These protocols provide a comprehensive toolkit for investigating BAX activation mechanisms in mammalian cells.
    Keywords:  Apoptosis; BAX; BCL-2 family; Blue native PAGE; Cytochrome c release; Immunoblotting; Immunoprecipitation; Membrane potential; Mitochondria; Mitochondrial outer membrane permeabilization (MOMP); Mitochondrial translocation; Oligomerization; Size-exclusion chromatography; Subcellular fractionation
    DOI:  https://doi.org/10.1016/bs.mcb.2026.05.020
  2. Methods Cell Biol. 2026 ;pii: S0091-679X(26)00187-1. [Epub ahead of print]211 71-91
      Apoptosis and the clearance of dying cells are essential for organismal homeostasis. Excessive cell death contributes to neurodegeneration and autoimmunity, whereas insufficient apoptosis leads to uncontrolled proliferation and cancer. Mitochondria play a key role in the initiation and orchestration of apoptosis through mitochondrial outer membrane permeabilisation (MOMP). In response to cellular stress, BAX and BAK oligomerise to form pores on the mitochondrial outer membrane, forming conduits through which intermembrane space proteins such as cytochrome c enter the cytoplasm. There, cytochrome c binds APAF1 to form the apoptosome, which recruits and activates caspase-9, triggering downstream activation of caspases-3 and -7, resulting in cell death. MOMP is tightly regulated by the BCL-2 family of proteins, comprising pro-apoptotic effectors (BAX, BAK), pro-apoptotic BH3-only proteins (BID, BIM, PUMA) or anti-apoptotic members (BCL-2, BCL-xL, MCL1). In general, the activity of the pro-apoptotic members is counteracted by the expression of the anti-apoptotic members. However, disruption of this balance leads to induction or sensitisation towards MOMP, and therefore apoptosis. B cell development is governed by a fine balance between survival and apoptotic cell death. Genetic alterations in B cells often lead to overexpression of anti-apoptotic BCL-2 family members, tilting this balance towards survival and enabling defective or malignant B cells to evade cell death. To investigate how mitochondrial apoptotic priming shapes B cell development, we present a protocol for isolating primary mouse B cells that can be readily adapted to diverse disease, including B cell lymphomas. We also describe a BH3 profiling workflow, a robust, accessible assay that assesses mitochondrial apoptotic priming by exposing permeabilised cells to BH3 peptides or small molecule BH3 mimetics and quantifying MOMP by flow cytometric detection of cytochrome c release.
    Keywords:  Apoptosis regulation; B cells; BH3 profiling; Cell death; Flow cytometry; Immunology; Mitochondrial apoptosis; Mitochondrial priming
    DOI:  https://doi.org/10.1016/bs.mcb.2026.05.019
  3. Sci Adv. 2026 Nov 20. 12(47): eaeg4754
      Mitochondrial homeostasis is maintained by molecular chaperones and proteases located within the organelle. The mitochondrial matrix-localized protease LONP-1 degrades oxidatively damaged or misfolded proteins. Importantly, LONP-1 also regulates mitochondrial DNA replication. Here, we show that mutations in C. elegans that impair LONP-1 function cause dysregulation of mitochondrial DNA replication, mitochondrial RNA transcription and protein synthesis within the mitochondrial matrix. LONP-1 deficient worms had reduced levels of oxidative phosphorylation proteins despite increased mtDNA-encoded protein synthesis. Via a forward genetic screen, we identified three mutations that restored mitochondrial function and the rate of development in lonp-1 mutants to levels comparable to those in wildtype worms. Interestingly, all three suppressor mutations were found in genes encoding mitochondrial ribosome proteins. A point mutation in the mitochondrial ribosome protein MRPS-38 restored oxidative phosphorylation in lonp-1 mutant worms. Combined, our results suggest that LONP-1 regulates mitochondrial translation and that suppressor mutations within mrps-38 or mrps-15 can enhance oxidative phosphorylation complex assembly when LONP-1 function is diminished.
    DOI:  https://doi.org/10.1126/sciadv.aeg4754
  4. Methods Cell Biol. 2026 ;pii: S0091-679X(26)00189-5. [Epub ahead of print]211 25-44
      Bcl-2 proteins are the central regulators of the intrinsic pathway of apoptosis. The multidomain pro-apoptotic members of the family, Bax and Bak, oligomerise to form large pores in the outer mitochondrial membrane (OMM) to initiate cell death. This process is antagonised by antiapoptotic Bcl-2 proteins such as Bcl-2, Bcl-XL and Mcl-1. The BH3-only subgroup of the Bcl-2 family interact with both the pro- and anti-apoptotic proteins to promote OMM permeabilization, either by directly activating Bax and Bak, or by inhibiting the anti-apoptotic proteins. The overall level of interaction and expression of these different subsets of Bcl-2 proteins sets the threshold for MOMP, termed apoptotic or mitochondrial priming. Adding further to the complexity are a multitude of what could be termed non-canonical interactions reported in the literature which can influence Bcl-2 proteins. Investigating these interactions in live cells is therefore important to gain a holistic understanding of how apoptosis is regulated. Here we describe approaches to use proximity biotin labelling identification (BioID) to study in situ interactions of Bcl-2 proteins.
    Keywords:  Apoptosis; Bcl-2 proteins; BioID; Mass spectrometry
    DOI:  https://doi.org/10.1016/bs.mcb.2026.05.021
  5. bioRxiv. 2025 Nov 03. pii: 2025.11.01.686055. [Epub ahead of print]
      The tumor microenvironment (TME) programs cancer cells to influence therapeutic responses. Macrophages residing in TME switch from pro-phagocytic to tumor-promoting and immunosuppressive phenotypes as cancer develops. While these pro-tumor functions of macrophages are associated with poor outcomes, the underlying mechanisms by which bone-marrow (BM)-associated macrophages fuel myeloid malignancy and their precise contribution to relapse remain undissected. Here, we show expansion of monocyte/macrophage population in leukemia patients post-chemotherapy relapse, and spatial proximity of macrophages to leukemia blasts in the BM niche. This proximity proved functionally consequential-depletion of macrophages delayed leukemia relapse post cytarabine (AraC), a frontline chemotherapy, in patient-derived xenografts (PDX) and syngeneic leukemia models. Mechanistically, a pyrimidine metabolite, deoxycytidine (dC), secreted by BM macrophages, is taken up by leukemia cells to directly inhibit deoxycytidine kinase (DCK) to hamper AraC activation and subsequent resistance in a cell non-autonomous manner. Diagnosis AML patients exhibited significantly higher circulating dC levels than healthy donors, and dC levels further increased following chemotherapy. SAMHD1, which catalyzes deoxynucleoside triphosphates (dNTPs) into deoxynucleoside, was highly abundant in macrophages and mediated dC accumulation. Blockade of dC production in mouse and human macrophages via genetic and pharmacological inhibition of SAMHD1 or DHODH , a critical enzyme in pyrimidine synthesis, restored AraC sensitivity. Combination with DHODH inhibitors significantly delayed AraC relapse in human PDX and mouse syngeneic AML models. Collectively, we identify a metabolic immune-leukemia crosstalk in which SAMHD1 high macrophages mediates chemoresistance by secreting pyrimidine metabolites and propose macrophage metabolic reprogramming as a tractable strategy to overcome TME-driven chemoresistance in myeloid leukemia.
    DOI:  https://doi.org/10.1101/2025.11.01.686055
  6. Methods Cell Biol. 2026 ;pii: S0091-679X(26)00190-1. [Epub ahead of print]211 113-143
      Mitochondria are indispensable organelles in the center of cellular bioenergetics, coupling oxidative phosphorylation to ATP production while also influencing processes such as cellular metabolism, oxidative stress regulation, reactive oxygen species (ROS) signaling, calcium buffering and apoptosis induction. Mitochondrial plasticity and remodeling shape the processes of cell differentiation, immune activation, senescence, and cancerogenesis. Their functional state is shaped by dynamic remodeling and frequently altered by pharmacological treatments, genetic mutations, aging, and cell dysfunction in association with diseases. Key parameters reflecting mitochondrial status include membrane potential (MMP), mitochondrial reactive oxygen species (mitoROS) and mitochondrial biomass. Here, we describe a unified, flow cytometry-based protocol for sequential quantification of these parameters in a single cell preparation using three fluorescent probes: MitoTracker Green FM for mitochondrial biomass, JC-1 for ratiometric measurement of MMP, and MitoSOX Red for mitoROS. The method is compatible with both adherent and suspension cells, provides single-cell resolution, and enables high-throughput profiling across high number of conditions and treatments. We demonstrate its utility in colorectal cancer cell lines with contrasting metabolic phenotypes (OXPHOS-reliant SW1417 and glycolytic COLO-320) exposed to chemotherapeutics and metabolic inhibitors. This parallel assay provides an efficient and scalable approach to interrogate mitochondrial functionality under diverse conditions. It is particularly valuable for studies of metabolic remodeling and cell stress responses, offering a practical alternative or complement to respirometry-based assays.
    Keywords:  Cell death; MMP; Mitochondria; OXPHOS; ROS
    DOI:  https://doi.org/10.1016/bs.mcb.2026.05.022
  7. bioRxiv. 2026 Nov 13. pii: 2026.11.12.766318. [Epub ahead of print]
      NRF2 hyperactivation caused by mutations in KEAP1 or NFE2L2 occurs in 20-30% of non-small cell lung cancers and confers therapy resistance. Here we show that NRF2-driven metabolic reprogramming creates a selective vulnerability to selenite. NRF2-dependent thiol export promotes the extracellular reduction of selenite to selenide. Our data support a model in which selenide enters cells and reaches mitochondria, where sulfide-quinone oxidoreductase uses selenide and glutathione to generate the selenopersulfide GS-SeH. A four-hour pulse of selenite was sufficient to induce cell death after washout, consistent with a selenium redox cycle that consumes NADPH and regenerates selenide. Within hours, selenite abolished aconitase activity and impaired mitochondrial respiration. The resulting cell death occurred independently of apoptosis, ferroptosis, pyroptosis, necroptosis and disulfidptosis. In mice, a selenite-rich diet selectively suppressed the growth of NRF2-hyperactive tumors. These findings identify an NRF2-driven metabolic vulnerability and support further investigation of selenite as a therapeutic strategy for NRF2-hyperactive cancers.
    DOI:  https://doi.org/10.64898/2026.11.12.766318
  8. Cell Rep. 2026 Nov 14. pii: S2211-1247(26)01361-6. [Epub ahead of print]45(11): 118282
      Clear cell renal cell carcinoma (ccRCC) is characterized by aberrant lipid accumulation and intrinsic ferroptosis sensitivity, yet how ccRCC escapes this vulnerability remains poorly understood. Here, we report that fumarate hydratase (FH) deficiency drives fumarate accumulation, which induces extensive remodeling of the ubiquitinated proteome and confers increased resistance to ferroptosis in ccRCC. Mechanistically, fumarate-mediated C706 succination of ubiquitin-like modifier-activating enzyme 1 (UBA1) significantly impairs its interaction with ubiquitin-conjugating enzyme E2 G2 (UBE2G2), concomitant with a global reduction of ubiquitination. Specifically, diminished ubiquitination increases the protein levels of activating transcription factor 4 (ATF4) and elevates solute carrier family 7 member 11 (SLC7A11) expression, thereby inhibiting ferroptosis. Importantly, a designed cell-penetrating peptide attenuates fumarate-induced UBA1 succination, suppresses ATF4-SLC7A11 axis, and enhances ferroptosis sensitivity of ccRCC. Collectively, these findings reveal that FH deficiency drives ubiquitinome dysregulation and suppresses ferroptosis, thereby linking ubiquitinated proteome reprogramming to tumor progression and suggesting potential therapeutic targets and strategies for treating ccRCC.
    Keywords:  CP: cancer; CP: metabolism; ccRCC; ferroptosis; fumarate; succination; ubiquitinated proteome
    DOI:  https://doi.org/10.1016/j.celrep.2026.118282